Emily Minkow

Corporate Officer/Principal en PREVAIL THERAPEUTICS INC. .

41 años

Health Technology

Consumer Services

Finance

Perfil

Emily Minkow is currently the Director at Stylus Medicine, Inc. and a Venture Partner at RA Capital Management LP (Private Equity).
She was previously the Chief Business Officer at Prevail Therapeutics, Inc. and the Executive Director-Business Development at Celgene Corp.
Ms. Minkow received her undergraduate degree from Princeton University and her MBA from Harvard Business School.

Cargos activos de Emily Minkow

Empresas	Cargo	Inicio
PREVAIL THERAPEUTICS INC.	Corporate Officer/Principal	01/11/2018
RA Capital Management LP (Private Equity) RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA.	Inversor de Capital Privado	01/01/2022
Stylus Medicine, Inc. Stylus Medicine, Inc. Medical SpecialtiesHealth Technology Stylus Medicine, Inc. is a company focused on developing innovative solutions to combat diseases using cutting-edge genome engineering and chromatin regulation technologies. Stylus Medicine is based in Boston, MA. The company is backed by RA Ventures and Khosla Ventures.	Director/Miembro de la Junta	-

Todos los cargos activos de Emily Minkow

Antiguos cargos conocidos de Emily Minkow.

Empresas	Cargo	Fin
CELGENE	Corporate Officer/Principal	01/10/2017

Ver el detalle de la experiencia de Emily Minkow.

Formación de Emily Minkow.

Princeton University	Undergraduate Degree
Harvard Business School	Masters Business Admin

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Emily Minkow.

Relaciones

100 +

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	4
Celgene Corp. Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ.	Health Technology
Prevail Therapeutics, Inc. Prevail Therapeutics, Inc. BiotechnologyHealth Technology Prevail Therapeutics, Inc. develops therapeutics for neurodegenerative diseases. The firm engages in the research and development of novel biologic gene therapies to treat Parkinson's disease and other neurodegenerative diseases. The company was founded by Asa Abeliovich on July 6, 2017 and is headquartered in New York, NY.	Health Technology
RA Capital Management LP (Private Equity) RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA.	Finance
Stylus Medicine, Inc. Stylus Medicine, Inc. Medical SpecialtiesHealth Technology Stylus Medicine, Inc. is a company focused on developing innovative solutions to combat diseases using cutting-edge genome engineering and chromatin regulation technologies. Stylus Medicine is based in Boston, MA. The company is backed by RA Ventures and Khosla Ventures.	Health Technology

Ver las conexiones de la empresa